Rebuttal from authors re: James W.F. Catto. More nomograms or better evidence of efficacy: what do we need in urologic oncology? Eur Urol 2008;54:11-12

Eur Urol. 2008 Jul;54(1):13-5. doi: 10.1016/j.eururo.2008.02.029. Epub 2008 Mar 4.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Humans
  • Male
  • Nomograms*
  • Prognosis
  • Prostatic Neoplasms / surgery*
  • Prostatic Neoplasms / therapy
  • Risk Assessment